Products for Research Use Only
RegisterLogin

Zharp1-211

CAT: 0804-HY-161060-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-161060-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Zharp1-211 is a RIPK1 kinase inhibitor with an EC50 of 53 nM and a Kd of 8.7 nM. Zharp1-211 reduces IFN-γ-induced STAT1 activation. Zharp1-211 can be used in the research of graft-versus-host disease and colon cancer[1].
CAS Number
2258671-41-7
UNSPSC
12352005
Target
RIP kinase; STAT
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zharp1-211.html
Purity
99.15
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(OC1CCOCC1)N2C3=CC(C(C=C4)=CN5C4=NC(NC(C6CC6)=O)=C5)=CN=C3CC2
Molecular Formula
C24H25N5O4
Molecular Weight
447.49
References & Citations
[1]Yu X, et al. A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis. Blood. 2023 Mar 2;141 (9) :1070-1086.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1; STAT1

Related Products

CatalogName
HY-178163Zharp1-163
HY-111455-01LP-211
HY-122703BETi-211
HY-131223-01NDSB-211
HY-107364-01MTX-211
HY-105998AVN-211
HY-128035-01ML-211
HY-171115-01Pyrone-211
HY-P991469AMG-211
HY-122185-01Anticancer agent 211

Alternative Products

CatalogName
BUP21043-01Zharp1-211
GTR19273210-01Zharp1-163
BA4998-10LP-211
BA6343-5MTX-211
B5343-10HU 211
C3647-1ML-211
T9901A-1607-01AMG-211
T205344-01Pyrone-211
T26780-01BETi-211
2133-5GNDSB-211

Popular Products